China Pharma Holdings, Inc.
CPHI
$1.43
$0.0151.06%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.66M | -4.57M | -4.74M | -4.74M | -4.40M |
| Total Depreciation and Amortization | 1.80M | 2.21M | 2.62M | 2.87M | 2.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 462.30K | 544.30K | 456.40K | 469.00K | 421.20K |
| Change in Net Operating Assets | 1.82M | 1.87M | 1.20M | 682.10K | 1.46M |
| Cash from Operations | 424.80K | 61.00K | -466.40K | -727.20K | 327.10K |
| Capital Expenditure | -68.50K | -96.70K | -38.40K | -23.40K | -39.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -60.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -285.90K | -275.90K | -253.30K | -- | -- |
| Cash from Investing | -354.60K | -372.80K | -291.80K | -23.40K | -100.10K |
| Total Debt Issued | 1.01M | 520.10K | 520.10K | 1.58M | 1.55M |
| Total Debt Repaid | -1.09M | -569.60K | -492.80K | -1.53M | -1.98M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -100.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -85.60K | -49.50K | 27.40K | 51.00K | -432.20K |
| Foreign Exchange rate Adjustments | -99.00K | -65.00K | -66.30K | 48.30K | 42.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.30K | -426.10K | -796.90K | -651.10K | -162.50K |